Back to PathoKing

DIC module

Disseminated Intravascular Coagulation

Follow systemic coagulation activation through microvascular fibrin, factor and platelet consumption, bleeding, organ injury, and trigger-led treatment.

advanced31 min

Clinically reviewed by Mark · NMC-registered nurse

Aetiology

What starts Disseminated Intravascular Coagulation?

Different triggers converge on the condition's central pathological process.

Sepsis

Typical setting: Pathogen products and cytokines activate monocytes and endothelium.

Widespread tissue-factor expression, anticoagulant failure, and endothelial injury generate systemic thrombin.

Major trauma or burns

Typical setting: Extensive tissue damage exposes procoagulants and causes shock.

Tissue factor, hypoperfusion, acidosis, and inflammation destabilise haemostasis.

Obstetric catastrophe

Typical setting: Placental abruption, amniotic fluid embolism, retained dead fetus, or severe postpartum haemorrhage releases potent procoagulants.

Rapid thrombin generation can consume haemostatic reserves within hours.

Malignancy

Typical setting: Solid tumours and haematological cancers express procoagulant material.

Chronic or acute activation occurs, with APL especially associated with dangerous bleeding.

Severe tissue destruction

Typical setting: Pancreatitis, shock, incompatible transfusion, or vascular lesions activate coagulation.

Endothelial injury and circulating procoagulants exceed local regulatory capacity.

Mechanism chain

Cause and effect

Follow each link and use it to predict the next clinical consequence.

1

A major trigger exposes tissue factor

Inflammation or tissue destruction activates coagulation throughout the circulation.

2

Thrombin generation escapes local control

Natural anticoagulant pathways are overwhelmed or downregulated.

Checking account access...